Holding(s) in Company
04 February 2005 - 3:24AM
UK Regulatory
RNS Number:2028I
Cambridge Antibody Tech Group PLC
03 February 2005
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1) Name of company
Cambridge Antibody Technology
2) Name of shareholder having a major interest
The Goldman Sachs Group Inc
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them
As in 2 above
5) Number of shares/amount of stock acquired
Nil
6) Percentage of issued class
Nil
7) Number of shares/amount of stock disposed
None
8) Percentage of issued class
N/A
9) Class of security
Ordinary 10 pence shares
10) Date of transaction
Not known
11) Date company informed
2 February 2005
12) Total holding following this notification
Not disclosed
13) Total percentage holding of issued class following this notification
Not known
14) Any additional information
the Goldman Sachs Group, Inc no longer have a disclosable interest
15) Name of contact and telephone number for queries
Justin Hoskins 01223 898589
16) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of notification 3 February 2005
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAKADEAFSEFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024